Clinical trial
A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy…
NCT00447278 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00447278 |
|---|---|
| Title | A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents |
| Official title | A Randomized, Controlled, Open-Label Study of the Long-Term Impact on Functioning Using Atomoxetine Hydrochloride Compared to Other Early Standard Care in the Treatment of Attention-Deficit/Hyperactivity Disorder in Treatment-Naïve Children and Adolescents |
| Acronym | ADHD LIFE |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | Atomoxetine, Other standard therapy for ADHD |
| Enrollment | 399 |
| Start date | Mar 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Mar 14, 2007 |
| Last update posted | Apr 27, 2010 |
| Countries | Belgium, France, Ireland, Italy, Mexico, Norway, Spain, Turkey (Türkiye), United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: